Unaudited standalone Financial Result for the quarter ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemiesynth (Vapi) Ltd reported its Q3 FY26 unaudited results with revenue from operations of about Rs 508.66 lakh, up roughly 31% from Rs 388.04 lakh in the same quarter last year. For the nine months ended December 2025, revenue rose about 31% to Rs 1,593.27 lakh versus Rs 1,220.26 lakh a year earlier. Despite the strong top-line growth, the company slipped deeper into the red, posting a net loss of Rs 69.71 lakh in Q3 (vs Rs 46.93 lakh loss YoY) and a nine-month loss of Rs 159.29 lakh (vs Rs 29.47 lakh loss YoY). Loss per share widened to Rs 2.27 for the quarter and Rs 5.19 for nine months. The statutory auditor issued an unqualified limited review report, and the Board also approved the reconstitution of the Nomination & Remuneration Committee.
Strong revenue growth is being more than offset by rising costs and finance charges, leading to widening losses and negative EPS - this is likely to weigh on the stock in the short term as investors watch for signs of margin recovery.